IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 147 filers reported holding IMMUNITYBIO INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $407,915 | -0.3% | 146,732 | -34.7% | 0.00% | – |
Q1 2023 | $409,056 | +72.2% | 224,756 | +379.6% | 0.00% | – |
Q4 2022 | $237,581 | +152.7% | 46,860 | +148.3% | 0.00% | – |
Q3 2022 | $94,000 | -40.9% | 18,874 | -55.7% | 0.00% | – |
Q2 2022 | $159,000 | -90.2% | 42,605 | -85.3% | 0.00% | – |
Q1 2022 | $1,630,000 | +37.0% | 290,306 | +48.3% | 0.00% | – |
Q4 2021 | $1,190,000 | -12.4% | 195,803 | +40.4% | 0.00% | – |
Q3 2021 | $1,359,000 | -50.3% | 139,458 | -27.2% | 0.00% | -100.0% |
Q2 2021 | $2,734,000 | -69.9% | 191,448 | -50.0% | 0.00% | -80.0% |
Q1 2021 | $9,085,000 | – | 382,676 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |